TY - JOUR
T1 - Epigenomic regulation of bile acid metabolism
T2 - Emerging role of transcriptional cofactors
AU - Smith, Zachary
AU - Ryerson, Daniel
AU - Kemper, Jongsook Kim
N1 - Funding Information:
We apologize to those authors whose original works were not discussed in this review due to space limitations. We thank Byron Kemper for critical reading of the manuscript. This work was supported by NIH Grant DK062777 and an ADA basic research award to J.K.K.
PY - 2013/4/10
Y1 - 2013/4/10
N2 - The traditional role of bile acids is to simply facilitate absorption and digestion of lipid nutrients, but bile acids also act as endocrine signaling molecules that activate nuclear and membrane receptors to control integrative metabolism and energy balance. The mechanisms by which bile acid signals are integrated to regulate target genes are, however, largely unknown. Recently emerging evidence has shown that transcriptional cofactors sense metabolic changes and modulate gene transcription by mediating reversible epigenomic post-translational modifications (PTMs) of histones and chromatin remodeling. Importantly, targeting these epigenomic changes has been a successful approach for treating human diseases, especially cancer. Here, we review emerging roles of transcriptional cofactors in the epigenomic regulation of liver metabolism, especially focusing on bile acid metabolism. Targeting PTMs of histones and chromatin remodelers, together with the bile acid-activated receptors, may provide new therapeutic options for bile acid-related disease, such as cholestasis, obesity, diabetes, and entero-hepatic cancers.
AB - The traditional role of bile acids is to simply facilitate absorption and digestion of lipid nutrients, but bile acids also act as endocrine signaling molecules that activate nuclear and membrane receptors to control integrative metabolism and energy balance. The mechanisms by which bile acid signals are integrated to regulate target genes are, however, largely unknown. Recently emerging evidence has shown that transcriptional cofactors sense metabolic changes and modulate gene transcription by mediating reversible epigenomic post-translational modifications (PTMs) of histones and chromatin remodeling. Importantly, targeting these epigenomic changes has been a successful approach for treating human diseases, especially cancer. Here, we review emerging roles of transcriptional cofactors in the epigenomic regulation of liver metabolism, especially focusing on bile acid metabolism. Targeting PTMs of histones and chromatin remodelers, together with the bile acid-activated receptors, may provide new therapeutic options for bile acid-related disease, such as cholestasis, obesity, diabetes, and entero-hepatic cancers.
KW - Chromatin remodeling
KW - Coregulators
KW - FGF15
KW - Histone modification
KW - Liver metabolism
KW - Post-translational modification
UR - http://www.scopus.com/inward/record.url?scp=84875272845&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875272845&partnerID=8YFLogxK
U2 - 10.1016/j.mce.2012.04.008
DO - 10.1016/j.mce.2012.04.008
M3 - Review article
C2 - 22579755
AN - SCOPUS:84875272845
SN - 0303-7207
VL - 368
SP - 59
EP - 70
JO - Molecular and Cellular Endocrinology
JF - Molecular and Cellular Endocrinology
IS - 1-2
ER -